tiprankstipranks
Abbott Labs (DE:ABL)
XETRA:ABL

Abbott Labs (ABL) Stock News & Sentiment

5 Followers
Abbott price target lowered to $140 from $141 at Barclays
PremiumThe Fly
Abbott price target lowered to $140 from $141 at Barclays
7d ago
Abbott Q1 strong but still in penalty box on litigation overhang, says Bernstein
PremiumThe Fly
Abbott Q1 strong but still in penalty box on litigation overhang, says Bernstein
11d ago
Abbott price target lowered to $125 from $128 at RBC Capital
PremiumThe Fly
Abbott price target lowered to $125 from $128 at RBC Capital
11d ago
Abbott price target lowered to $124 from $127 at Raymond James
PremiumThe Fly
Abbott price target lowered to $124 from $127 at Raymond James
11d ago
Abbott says performance of business continues to be ‘very strong’
PremiumThe Fly
Abbott says performance of business continues to be ‘very strong’
12d ago
Unusually active option classes on open April 17th
PremiumThe Fly
Unusually active option classes on open April 17th
12d ago
Abbott says broad-based growth across portfolio in Q1
PremiumThe Fly
Abbott says broad-based growth across portfolio in Q1
12d ago
More ABT News >

News Score - Last 7 Days

Neutral
DE:ABL
Sector Average
Media Buzz
This Week8 articles
Weekly Average26.5 articles
News Sentiment
This Week100%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:ABL’s Media Buzz Sentiment?
8 articles about DE:ABL were published this week. In an average week, 26.5 articles are published.
    What is DE:ABL’s weekly average amount of articles?
    In an average week, 26.5 articles about DE:ABL are published.
      What is DE:ABL’s News Sentiment?
      100% of articles about DE:ABL were positive this week, compared to its sector average of 59%.
        Healthcare Stocks that are Trending in the News
        RMDResmed
        AMEDAmedisys
        MORFMorphic Holding
        NBIXNeurocrine
        TAKTakeda Pharmaceutical Company
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis